EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells

Michelle A Lum, Kayla A Jonas, Shreya Parmar, Adrian R Black, Caitlin M O'Connor, Stephanie Dobersch, Naomi Yamamoto, Tess M Robertson, Aidan Schutter, Miranda Giambi, Rita A Avelar, Analisa DiFeo und 4 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci176093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Michelle A Lum und 15 weiteren Autor:innen. Beteiligte Einrichtung: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Protein Phosphatase 2, Adaptor Proteins, Signal Transducing, Eukaryotic Initiation Factor-4E, Protein Biosynthesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, DOD Peer Reviewed Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated eIF4E-dependent translation is a central driver of tumorigenesis and therapy resistance. eIF4E-binding proteins (4E-BP1/2/3) are major negative regulators of eIF4E-dependent translation that are inactivated in tumors through inhibitory phosphorylation or downregulation. Previous studies have linked PP2A phosphatase(s) to activation of 4E-BP1. Here, we leveraged biased small-molecule activators of PP2A (SMAPs) to explore the role of B56-PP2A(s) in 4E-BP regulation and the potential of B56-PP2A activation for restoring translational control in tumors. SMAP treatment promoted PP2A-dependent hypophosphorylation of 4E-BP1/2, supporting a role for B56-PP2As (e.g., B56α-PP2A) as 4E-BP phosphatases. Unexpectedly, SMAPs induced transcriptional upregulation of 4E-BP1 through a B56-PP2A→TFE3/TFEB→ATF4 axis. Cap-binding and coimmunoprecipitation assays showed that B56-PP2A(s) activation blocks assembly of the eIF4F translation initiation complex, and cap-dependent translation assays confirmed the translation-inhibitory effects of SMAPs. Thus, B56-PP2A(s) orchestrate a translation-repressive program involving transcriptional induction and activation of 4E-BP1. Notably, SMAPs promoted 4E-BP1–dependent apoptosis in tumor cells and potentiated 4E-BP1 function in the presence of ERK or mTOR inhibitors, agents that rely on inhibition of eIF4E-dependent translation for antitumor activity. These findings, combined with the ability of SMAPs to regulate 4E-BP1 in vivo, highlight the potential of PP2A activators for cancer therapy and overcoming therapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Phosphatase 2Adaptor Proteins, Signal TransducingEukaryotic Initiation Factor-4EProtein BiosynthesisPhosphoproteinsNeoplasmsEukaryotic Initiation FactorsSmall Molecule LibrariesNeoplasm ProteinsHumansMiceAnimalsCell Cycle ProteinsCell Line, TumorActivating Transcription Factor 4Phosphorylation

Stichwörter der Autor:innen

Cell biologyOncologyPhosphoprotein phosphatasesSignal transductionTranslation

Substanzen

Protein Phosphatase 2EIF4EBP1 protein, humanAdaptor Proteins, Signal TransducingCell Cycle ProteinsEukaryotic Initiation Factor-4EEIF4E protein, humanPhosphoproteinsEIF4EBP2 protein, humanEukaryotic Initiation FactorsActivating Transcription Factor 4

Autor:innen und Institutionen

  • Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Fred and Pamela Buffett Cancer Center, Omaha, Nebraska, USA.
  • Division of Genetic Medicine, Department of Internal Medicine, and.
  • Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Department of Pathology and.

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • DOD Peer Reviewed Cancer Research Program
  • Rogel Scholar Award
  • NIH
  • UNMC
  • Nebraska Department of Health and Human Services

Zitieren

APA

Lum, M. A., Jonas, K. A., Parmar, S., Black, A. R., O'Connor, C. M., Dobersch, S., Yamamoto, N., Robertson, T. M., Schutter, A., Giambi, M., Avelar, R. A., DiFeo, A., Woods, N. T., Kugel, S., Narla, G., & Black, J. D. (2025). Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells. Journal of Clinical Investigation. https://doi.org/10.1172/jci176093

Vancouver

Lum MA, Jonas KA, Parmar S, Black AR, O'Connor CM, Dobersch S, et al. Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells. Journal of Clinical Investigation. 2025. doi:10.1172/jci176093

BibTeX
@article{Lum2025,
  author = {Lum, Michelle A and Jonas, Kayla A and Parmar, Shreya and Black, Adrian R and O'Connor, Caitlin M and Dobersch, Stephanie and Yamamoto, Naomi and Robertson, Tess M and Schutter, Aidan and Giambi, Miranda and Avelar, Rita A and DiFeo, Analisa and Woods, Nicholas T and Kugel, Sita and Narla, Goutham and Black, Jennifer D},
  title = {Small-molecule modulators of B56-PP2A restore 4E-BP function to suppress eIF4E-dependent translation in cancer cells},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci176093}
}
Kostenlos starten →